Support us
Bernards
Rene Bernards

Rene Bernards

Group leader

Phone Email

René Bernards studied adenovirus transformation for his PhD research with Alex van der Eb in Leiden. He joined the laboratory of Robert Weinberg at the Whitehead Institute in Cambridge, USA for his postdoctoral training. He was appointed assistant professor at the Massachusetts General Hospital Cancer Center in 1988.

In 1992 he joined the Netherlands Cancer Institute in Amsterdam. In 1994 he was also appointed part time professor of molecular carcinogenesis at Utrecht University, The Netherlands.


Field of expertise

Cancer Genetics

Functional Genetics

Drug Resistance

Work Experience

2019 - present: Professor of Molecular Carcinogenesis Jiao Tong University Shanghai (part time)

2017 - present:Founding member Oncode Institute

2017 - present : Co-founder Oncosence BV

2015 - present:  Senior staff scientist, Netherlands Cancer Institute, Amsterdam

2015 - present: Co-founder Qameleon Therapeutics BV

2014 - 2015: Visiting scientist, Genentech Inc. South San Francisco, USA

2003 - present:  Co-founder and Chief Scientific Officer, Agendia NV, Amsterdam, The Netherlands (part time)

1994 – present:  Professor of Molecular Carcinogenesis Utrecht University (part time)

1992 – 2015: Head, Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam

1988 – 1994: Assistant Professor, Harvard University

1985 – 1988:  Postdoctoral fellow, Whitehead Institute for Biomedical Research, Cambridge, MA, USA. Robert Weinberg, advisor

1980 - 1984: Ph.D. University of Leiden (cum laude). Thesis title: Transformation and oncogenicity by human adenoviruses.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.